MEDX

MEDX
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic...
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
LLY | Eli Lilly and Company | 18.67% | 2.94K | $3.38M |
ABBV | AbbVie Inc. | 9.00% | 6.71K | $1.63M |
NVS | Novartis AG | 6.96% | 8.39K | $1.26M |
JNJ | Johnson & Johnson | 5.88% | 4.20K | $1.07M |
ALKS | Alkermes plc | 5.73% | 20.13K | $1.04M |
BMY | Bristol-Myers Squibb Company | 4.60% | 14.64K | $833.98K |
AZN | AstraZeneca PLC | 4.55% | 5.01K | $824.97K |
AMGN | Amgen Inc. | 4.04% | 2.06K | $732.53K |
MRK | Merck & Co., Inc. | 3.91% | 5.87K | $709.22K |
ALNY | Alnylam Pharmaceuticals, Inc. | 3.36% | 2.17K | $609.77K |
IONS | Ionis Pharmaceuticals, Inc. | 3.30% | 10.90K | $598.96K |
PFE | Pfizer Inc. | 3.03% | 22.65K | $549.21K |
BIIB | Biogen Inc. | 2.89% | 2.73K | $523.26K |
GSK | GSK plc | 2.78% | 9.85K | $504.61K |
CRSP | CRISPR Therapeutics AG | 2.57% | 9.23K | $465.64K |
REGN | Regeneron Pharmaceuticals, Inc. | 2.28% | 630 | $413.36K |
BEAM | Beam Therapeutics Inc. | 1.43% | 8.39K | $259.11K |
GALT | Galectin Therapeutics Inc. | 1.38% | 46.97K | $250.81K |
NTLA | Intellia Therapeutics, Inc. | 0.92% | 12.58K | $167.37K |
VNDA | Vanda Pharmaceuticals Inc. | 0.73% | 22.65K | $132.49K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
LLY
Eli Lilly and Company
ABBV
AbbVie Inc.
NVS
Novartis AG
JNJ
Johnson & Johnson
ALKS
Alkermes plc
BMY
Bristol-Myers Squibb Company
AZN
AstraZeneca PLC
AMGN
Amgen Inc.
MRK
Merck & Co., Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
IONS
Ionis Pharmaceuticals, Inc.
PFE
Pfizer Inc.
BIIB
Biogen Inc.
GSK
GSK plc
CRSP
CRISPR Therapeutics AG
REGN
Regeneron Pharmaceuticals, Inc.
BEAM
Beam Therapeutics Inc.
GALT
Galectin Therapeutics Inc.
NTLA
Intellia Therapeutics, Inc.
VNDA
Vanda Pharmaceuticals Inc.
